Search research articles
Contact Us
Filters
Showing results (61-70 of 75) with videos related to
Page
of 8
Sort By:
Journal of the American College of Cardiology
|
September 1, 1997
Differences in myocardial velocity gradient measured throughout the cardiac cycle in patients with hypertrophic cardiomyopathy, athletes and patients with left ventricular hypertrophy due to hypertension
P Palka, A Lange, A D Fleming, et al.
Basic Research in Cardiology
|
August 30, 2002
Immunocytochemical evidence for inducible nitric oxide synthase and cyclooxygenase-2 expression with nitrotyrosine formation in human hibernating myocardium
Christopher S R Baker, David P Dutka, Domenico Pagano, et al.
Pacing and Clinical Electrophysiology : PACE
|
January 7, 2011
The impact of the right ventricular lead position on response to cardiac resynchronization therapy
Fakhar Z Khan, Pegah Salahshouri, Rudy Duehmke, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery
|
December 8, 2007
Perioperative myocardial injury after elective open abdominal aortic aneurysm repair predicts outcome
Z A Ali, C J Callaghan, A A Ali, et al.
Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society
|
August 28, 2018
Regulation of steroidogenic function of mouse Leydig cells: G-coupled membrane estrogen receptor and peroxisome proliferator-activated receptor partnership
E Gorowska-Wojtowicz, P Dutka, M Kudrycka, et al.
Tissue & Cell
|
November 25, 2019
Leydig cell tumorigenesis - implication of G-protein coupled membrane estrogen receptor, peroxisome proliferator-activated receptor and xenoestrogen exposure. In vivo and in vitro appraisal
E Gorowska-Wojtowicz, M Duliban, M Kudrycka, et al.
Journal of the American College of Cardiology
|
March 13, 2012
Targeted left ventricular lead placement to guide cardiac resynchronization therapy: the TARGET study: a randomized, controlled trial
Fakhar Z Khan, Mumohan S Virdee, Christopher R Palmer, et al.
JACC. Cardiovascular Interventions
|
February 22, 2015
Pre-treatment with glucagon-like Peptide-1 protects against ischemic left ventricular dysfunction and stunning without a detected difference in myocardial substrate utilization
Liam M McCormick, Stephen P Hoole, Paul A White, et al.
Coronary Artery Disease
|
May 15, 2009
Primary coronary microvascular dysfunction and poor coronary collaterals predict post-percutaneous coronary intervention cardiac necrosis
Stephen P Hoole, Paul A White, Patrick M Heck, et al.
Circulation
|
February 4, 2009
Cardiac Remote Ischemic Preconditioning in Coronary Stenting (CRISP Stent) Study: a prospective, randomized control trial
Stephen P Hoole, Patrick M Heck, Linda Sharples, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 75) with videos related to
Sort By:
Page
of 8
Journal of the American College of Cardiology
|
September 1, 1997
Differences in myocardial velocity gradient measured throughout the cardiac cycle in patients with hypertrophic cardiomyopathy, athletes and patients with left ventricular hypertrophy due to hypertension
P Palka, A Lange, A D Fleming, et al.
Basic Research in Cardiology
|
August 30, 2002
Immunocytochemical evidence for inducible nitric oxide synthase and cyclooxygenase-2 expression with nitrotyrosine formation in human hibernating myocardium
Christopher S R Baker, David P Dutka, Domenico Pagano, et al.
Pacing and Clinical Electrophysiology : PACE
|
January 7, 2011
The impact of the right ventricular lead position on response to cardiac resynchronization therapy
Fakhar Z Khan, Pegah Salahshouri, Rudy Duehmke, et al.
European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery
|
December 8, 2007
Perioperative myocardial injury after elective open abdominal aortic aneurysm repair predicts outcome
Z A Ali, C J Callaghan, A A Ali, et al.
Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society
|
August 28, 2018
Regulation of steroidogenic function of mouse Leydig cells: G-coupled membrane estrogen receptor and peroxisome proliferator-activated receptor partnership
E Gorowska-Wojtowicz, P Dutka, M Kudrycka, et al.
Tissue & Cell
|
November 25, 2019
Leydig cell tumorigenesis - implication of G-protein coupled membrane estrogen receptor, peroxisome proliferator-activated receptor and xenoestrogen exposure. In vivo and in vitro appraisal
E Gorowska-Wojtowicz, M Duliban, M Kudrycka, et al.
Journal of the American College of Cardiology
|
March 13, 2012
Targeted left ventricular lead placement to guide cardiac resynchronization therapy: the TARGET study: a randomized, controlled trial
Fakhar Z Khan, Mumohan S Virdee, Christopher R Palmer, et al.
JACC. Cardiovascular Interventions
|
February 22, 2015
Pre-treatment with glucagon-like Peptide-1 protects against ischemic left ventricular dysfunction and stunning without a detected difference in myocardial substrate utilization
Liam M McCormick, Stephen P Hoole, Paul A White, et al.
Coronary Artery Disease
|
May 15, 2009
Primary coronary microvascular dysfunction and poor coronary collaterals predict post-percutaneous coronary intervention cardiac necrosis
Stephen P Hoole, Paul A White, Patrick M Heck, et al.
Circulation
|
February 4, 2009
Cardiac Remote Ischemic Preconditioning in Coronary Stenting (CRISP Stent) Study: a prospective, randomized control trial
Stephen P Hoole, Patrick M Heck, Linda Sharples, et al.
Page
of 8